The incidence of malignant mammary tumors (MMT) is one of the first among oncological diseases in the world and in Turkmenistan. According to the WHO data, 1 million 700 thousand women fall ill annually in the world [1].

Immunohistochemical (IHC) and other molecular genetic studies are of great importance in determining the biological characteristics of MMT [2-4].